Stability and in vitro antiproliferative activity of bioactive " Vitamin E" fortified parenteral lipid emulsions

Colloids and Surfaces B: Biointerfaces

Volumn 103, Issue , 2013, Pages 23-30

  Alayoubi, Alaadin ^a   Kanthala, Shanthi ^a   Satyanarayanajois, Seetharama D ^a   Anderson, John F ^a   Sylvester, Paul W ^a   Nazzal, Sami ^a  

^a UNIVERSITY OF LOUISIANA AT MONROE   (United States)

Author keywords

Lipid emulsion; Stability; Tocopherol; Tocotrienol; Vitamin E

Indexed keywords

ANTICANCER ACTIVITIES; ANTIPROLIFERATIVE ACTIVITIES; ANTIPROLIFERATIVE EFFECT; CELL LINES; ELECTROLYTE STABILITY; HEAD GROUPS; HUMAN COLON; IN-VITRO; INHIBITORY CONCENTRATION; LIPID EMULSIONS; OIL PHASE; PHYSICAL STRESS; POLOXAMER; POLYOXYETHYLENE; SODIUM DEOXYCHOLATE; SODIUM OLEATE; STERIC EFFECT; TOCOPHEROL; TOCOTRIENOLS; VITAMIN-E;

CELL CULTURE; CONVERGENCE OF NUMERICAL METHODS; ELECTROLYTES; EMULSIFICATION; POLYETHYLENE OXIDES; SODIUM;

EMULSIONS;

ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; DEOXYCHOLATE SODIUM; EMULSIFYING AGENT; OLEATE SODIUM; POLOXAMER; POLYOXYETHYLENE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG STABILITY; ELECTROLYTE METABOLISM; EMULSION; HEMOLYSIS; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LIPID ANALYSIS; PHYSICAL STRESS; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG STABILITY; ELECTROLYTES; EMULSIFYING AGENTS; HEMOLYSIS; HUMANS; LIPIDS; PARTICLE SIZE; POLOXAMER; RABBITS; TOCOPHEROLS; TOCOTRIENOLS; VITAMIN E;

EID: 84870166449     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2012.10.003     Document Type: Article

References (23)

1. Constantinides P., Han J., Davis S. Advances in the use of tocols as drug delivery vehicles. Pharm. Res. 2006, 23:243-255.
2. Cheong J.N., Tan C.P., Man Y.B.C., Misran M. α-Tocopherol nanodispersions: preparation, characterization and stability evaluation. J. Food Eng. 2008, 89:204-209.
3. Ali H., Shirode A.B., Sylvester P.W., Nazzal S. Preparation and in vitro antiproliferative effect of tocotrienol loaded lipid nanoparticles. Colloids Surf. A Physicochem. Eng. Asp. 2010, 353:43-51.
4. Jumaa M., Müller B.W. Parenteral emulsions stabilized with a mixture of phospholipids and PEG-660-12-hydroxy-stearate: evaluation of accelerated and long-term stability. Eur. J. Pharm. Biopharm. 2002, 54:207-212.
5. Han J., Davis S.S., Papandreou C., Melia C.D., Washington C. Design and Evaluation of an emulsion vehicle for paclitaxel. I. Physicochemical properties and plasma stability. Pharm. Res. 2004, 21:1573-1580.
6. Alayoubi A., Nazzal M., Sylvester P.W., Nazzal S. Vitamin E fortified parenteral lipid emulsions: plackett-burman screening of primary process and composition parameters. Drug Dev. Ind. Pharm. 2012.
7. Jumaa M., Müller B.W. Development of a novel parenteral formulation for tetrazepam using a lipid emulsion. Drug Dev. Ind. Pharm. 2001, 27:1115-1121.
8. Bock T.K., Müller B.W. A novel assay to determine the hemolytic activity of drugs incorporated in colloidal carrier systems. Pharm. Res. 1994, 11:589-591.
9. Jumaa M., Kleinebudde P., Müller B.W. Physicochemical properties and hemolytic effect of different lipid emulsion formulations using a mixture of emulsifiers. Pharm. Acta Helv. 1999, 73:293-301.
10. Han J., Davis S.S., Washington C. Physical properties and stability of two emulsion formulations of propofol. Int. J. Pharm. 2001, 215:207-220.
11. Whateley T.L., Steele G., Urwin J., Smail G.A. Particle size stability of intralipid and mixed total parenteral nutrition mixtures. J. Clin. Pharm. Ther. 1984, 9:113-126.
12. Washington C. Stability of lipid emulsions for drug delivery. Adv. Drug Deliv. Rev. 1996, 20:131-145.
13. Macdonald P.M., Seelig J. Calcium binding to mixed phosphatidylglycerol-phosphatidylcholine bilayers as studied by deuterium nuclear magnetic resonance. Biochemistry 1987, 26:1231-1240.
14. Gao K., Sun J., Liu K., Liu X., He Z. Preparation and characterization of a submicron lipid emulsion of docetaxel: submicron lipid emulsion of docetaxel. Drug Dev. Ind. Pharm. 2008, 34:1227-1237.
15. Ilium L., Davis S.S., Wilson C.G., Thomas N.W., Frier M., Hardy J.G. Blood clearance and organ deposition of intravenously administered colloidal particles. The effects of particle size, nature and shape. Int. J. Pharm. 1982, 12:135-146.
16. Hunter R.J. Foundations of colloid science 2001, Oxford University Press, New York, NY.
17. Lin W., Garnett M.C., Schacht E., Davis S.S., Illum L. Preparation and in vitro characterization of HSA-mPEG nanoparticles. Int. J. Pharm. 1999, 189:161-170.
18. Hung C.-F., Fang C.-L., Liao M.-H., Fang J.-Y. The effect of oil components on the physicochemical properties and drug delivery of emulsions: tocol emulsion versus lipid emulsion. Int. J. Pharm. 2007, 335:193-202.
19. Ishii F., Nagasaka Y. Interaction between erythrocytes and free phospholipids as an emulsifying agent in fat emulsions or drug carrier emulsions for intravenous injections. Colloids Surf. B: Biointerfaces 2004, 37:43-47.
20. Bjerregaard S., Wulf-Andersen L., Stephens R.W., Røge Lund L., Vermehren C., Söderberg I., Frokjaer S. Sustained elevated plasma aprotinin concentration in mice following intraperitoneal injections of w/o emulsions incorporating aprotinin. J. Control. Release 2001, 71:87-98.
21. El-Hariri L.M., Marriott C., Martin G.P. The mitigating effects of phosphatidylcholines on bile salt- and lysophosphatidylcholine-induced membrane damage. J. Pharm. Pharmacol. 1992, 44:651-654.
22. Forster D., Washington C., Davis S.S. Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocytes. J. Pharm. Pharmacol. 1988, 40:325-328.
23. Weingarten C., Santos Magalhaes N.S., Baszkin A., Benita S., Seiller M. Interactions of a non-ionic ABA copolymer surfactant with phospholipid monolayers: possible relevance to emulsion stabilization. Int. J. Pharm. 1991, 75:171-179.